The evaluation of canal wall up cholesteatoma surgery with the Glasgow Benefit Inventory

Westerberg, Johanna; Mäki‐Torkko, Elina; Harder, Henrik

doi:10.1007/s00405-019-05670-8

Cited by 5 publications

(7 citation statements)

References 21 publications

(40 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We are not aware of any studies systematically investigating the relationship between the cholesteatoma extent and HRQoL. Systematic studies addressing the HRQoL in cholesteatoma surgery are sparse, lack prospective evaluations and/or are mainly studying the influence of surgical techniques on HRQoL [ 18 , 20 , 27 , 30 , 31 ]. Lucidi et al as well as Lailach et al focused on the surgical approach and assessed HRQoL postoperatively using the Chronic Ear Survey (CES) and the Chronic Otitis Media Outcome Test (COMOT-15) [ 20 , 31 ].…”

Section: Discussionmentioning

confidence: 99%

“…Lucidi et al as well as Lailach et al focused on the surgical approach and assessed HRQoL postoperatively using the Chronic Ear Survey (CES) and the Chronic Otitis Media Outcome Test (COMOT-15) [ 20 , 31 ]. Westerberg et al investigated the postoperative HRQoL in patients undergoing canal wall up cholesteatoma surgery [ 30 ]. Nadol et al assessed HRQoL in a prospective setting comparing patients with active and inactive COM.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Mapping the ChOLE classification to hearing outcomes and disease-specific health-related quality of life

Weiss

Bächinger

Rrahmani

et al. 2020

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Objectives To investigate the association between the “ChOLE” classification, hearing outcomes and disease-specific health-related quality of life (HRQoL). Methods In two tertiary referral centers, patients requiring primary or revision surgery for cholesteatoma were assessed for eligibility. Audiometric assessment was performed pre- and postoperatively. The ChOLE classification was determined intraoperatively and via the preoperative CT scan. HRQoL was assessed pre- and postoperatively using the Zurich Chronic Middle Ear Inventory (ZCMEI-21). Results A total of 87 patients (mean age 45.2 years, SD 16.2) were included in this study. ChOLE stage I cholesteatoma was found in 8 (9%), stage II cholesteatoma was found in 65 (75%), and stage III cholesteatoma was found in 14 (16%) patients. Postoperatively, the mean air–bone gap (0.5, 1, 2, 3 kHz) was significantly smaller than before surgery (14.3 dB vs. 23.0 dB; p = 0.0007). The mean ZCMEI-21 total score significantly decreased after surgery (26.8 vs. 20.7, p = 0.004). No correlation between the ZCMEI-21 total score and both the ChOLE stage and the extent of the cholesteatoma (ChOLE subdivision “Ch”) was found. A trend towards worse HRQoL associated with a poorer status of the ossicular chain (ChOLE subdivision “O”) was observed. The audiometric outcomes were not associated with the extent of the cholesteatoma. The ChOLE subdivision describing the ossicular status showed a strong association with the pre- and postoperative air conduction (AC) thresholds. Further, the ZCMEI-21 total score and its hearing subscore correlated with the AC thresholds. Conclusion The ChOLE classification does not show a clear association with HRQoL measured by the ZCMEI-21. The HRQoL neither seems to be associated with the extent of the disease nor with the ossicular chain status. Yet, surgical therapy significantly improved HRQoL by means of reduced ZCMEI-21 total scores, which were strongly associated with the AC thresholds. Intraoperative assessment of a cholesteatoma using the ChOLE classification and HRQoL complement each other and provide useful information.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Mapping the ChOLE classification to hearing outcomes and disease-specific health-related quality of life

Weiss

Bächinger

Rrahmani

et al. 2020

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

show abstract

“…HRQoL studies on cholesteatoma surgery and stapes surgery observed positive benefit on the GBI total in 82% and 85% of the patients respectively (26,27). It must however be noted that in the study on cholesteatoma surgery, ossicular reconstruction was not performed in 12% (27). In general, GBI total benefit scores after BCD implantation appear to be at least comparable to those after reconstructive middle ear surgery.…”

Section: Discussionmentioning

confidence: 83%

“…The higher benefit percentage in the current study might be explained by advancements in sound processor technology or lower age. HRQoL studies on cholesteatoma surgery and stapes surgery observed positive benefit on the GBI total in 82% and 85% of the patients respectively (26,27). It must however be noted that in the study on cholesteatoma surgery, ossicular reconstruction was not performed in 12% (27).…”

Section: Discussionmentioning

confidence: 87%

Hearing-Related Quality of Life in 75 Patients With a Percutaneous Bone Conduction Device

Caspers

Nelissen

Groenewoud

et al. 2021

Otology &Amp; Neurotology

View full text Add to dashboard Cite

Objective: To evaluate long-term hearing-related quality of life (HRQoL) and device use in bone conduction (BCD) users. Furthermore, to assess differences between indications and changes in HRQoL over time. Study design: Prospective questionnaire survey. Setting: Tertiary referral center. Patients: Seventy-five patients with a percutaneous BCD. Main outcome measures: Glasgow Benefit Inventory (GBI) at 3 and 12 months postoperatively, Glasgow Health Status Inventory (GHSI) preoperatively, and 6 and 36 months postoperatively, device use at 6, 12, and 36 months. Changes over time were assessed and outcomes were compared between indications. Results: After implantation, 97% of all patients reported a positive benefit on the GBI total. The GHSI total had improved with median 15 points (Interquartile range [IQR] 12). At 36 months, median device use was 15 hours/day (IQR 10) and one nonuser was reported. Patients with bilateral hearing loss (BHL) showed greater improvement on the GHSI total (median 18 vs 14, p < 0.0001) and used their devices more frequently (median 16 vs 8 h/day, p < 0.0001) than patients with unilateral HL (UHL). Postoperative GHSI and GBI scores were consistent over time, in the entire patient population and for every indication. Between 6 and 36 months, device use was stable over time, except for patients with single-sided deafness (SSD; median À6.4 h/day, p ¼ 0.009). Conclusion:The BCD improves HRQoL in patients with BHL, in patients with unilateral conductive/mixed hearing loss and in patients with SSD. Patients with BHL experienced a greater improvement in hearing status compared to patients with UHL. Although use decreased over time in SSD patients, device use was high for every indication.

show abstract

“…To comprehensively evaluate the patient care experience, several disease-specific patient reported outcome measures have been developed and validated, such as the Chronic Ear Survey (CES) and the Chronic Otitis Media Outcome Test-15 (COMOT-15) (1,2). These and other general quality-of-life (QoL) measures have been used to assess QoL outcomes among patients with chronic otitis media after various otologic procedures, including intact canal wall and canal wall down tympanomastoidectomy (3–7), transcanal procedures (5), and canal wall down tympanomastoidectomy with mastoid cavity obliteration (8,9). However, to the authors' knowledge, no previous studies have evaluated the potential QoL benefits of subtotal petrosectomy with ear canal closure (STP) for recalcitrant chronic otitis media.…”

Section: Introductionmentioning

confidence: 99%

Quality-of-Life Outcomes After Modified Subtotal Petrosectomy With Ear Canal Closure for Chronic Otitis Media

et al. 2022

View full text Add to dashboard Cite

ObjectiveTo assess quality-of-life (QoL) outcomes after modified subtotal petrosectomy with ear canal closure (mSTP) for chronic otitis media.Study DesignSurvey study.SettingTertiary referral center.PatientsPatients with chronic otitis media.InterventionsmSTP.Main Outcome MeasuresSurvey results from enrolled patients on the validated disease-specific Chronic Ear Survey (CES) and Chronic Otitis Media Outcome Test-15 (COMOT-15) regarding their current state of health and, if surgery was performed within 3 years of enrollment, their state of health before mSTP.ResultsA total of 23 patients were studied, including 19 who underwent surgery within 3 years of enrollment. Postoperatively, mean total CES scores were 80 and COMOT-15 scores were 41, with a higher CES and a lower COMOT-15 indicating better QoL. There were statistically significant improvements after mSTP in the CES activity restriction (25% difference; p = 0.008), symptom (17% difference; p = 0.007), and medical resource (13% difference; p = 0.03) domain and total (18% difference; p = 0.006) scores. In addition, there were statistically significant improvements in the COMOT-15 ear symptom (−22% difference; p < 0.001) domain and total (−16% difference; p = 0.01) scores; however, improvements in the hearing function and mental health domains did not achieve statistical significance. Postoperative COMOT-15 total scores were significantly better for patients who underwent aural rehabilitation compared to those who did not (−17% difference; p < 0.001).ConclusionModified subtotal petrosectomy with ear canal closure is a useful intervention for patients with recalcitrant chronic otitis media, offering improved QoL in appropriately selected patients. Aural rehabilitation, when feasible, provides the potential for further QoL improvement.

show abstract

The evaluation of canal wall up cholesteatoma surgery with the Glasgow Benefit Inventory

Cited by 5 publications

References 21 publications

Mapping the ChOLE classification to hearing outcomes and disease-specific health-related quality of life

Mapping the ChOLE classification to hearing outcomes and disease-specific health-related quality of life

Hearing-Related Quality of Life in 75 Patients With a Percutaneous Bone Conduction Device

Quality-of-Life Outcomes After Modified Subtotal Petrosectomy With Ear Canal Closure for Chronic Otitis Media

Contact Info

Product

Resources

About